Columnist Oluwatosin Adesoye discusses the ongoing dilemma with sickle cell pain management for both patients and healthcare ...

More than 500,000 babies were tested for sickle cell disease in Catalonia’s newborn screening program, with 160 cases ...

Orna Therapeutics and Vertex will use lipid nanoparticle system to develop gene-editing therapies for people with SCD and TDT ...

It's not fully appreciated how much of an impact sickle cell disease can have on a person's mental health, writes columnist.

The European Commission has granted orphan drug status to mitapivat, an oral investigational therapy for sickle cell disease.

I wanted to start new habits at the end of last year instead of at the beginning of 2025. Several sources told me I didn’t need to wait until the start of a new year to make changes, so, in typical ...

The Gates Foundation will invest up to $50 million to support Tessera's SCD gene editing treatment, the company said.

Columnist Oluwatosin Adesoye shares a list of things that everyone should know and understand about sickle cell disease.